- >News: GenomeQuest and Roche 454 Team Up to Provide Next-Generation Sequence Search and Analysis Service >
- >News: GenomeQuest Announces Integration of GQ 5.0 with Invitrogen's Vector NTI Advance for Sequence Search >
Corporate Headquarters
GenomeQuest, Inc.
1700 West Park Drive, Suite 260
Westborough, MA 01581
Phone: 508 616 0100
Fax: 508 616 0110
Directions
Mon-Fri PM
Support Line: 774 242 6192
Europe Sales
GenomeQuest
62 Main Road
Long Hanborough
Oxfordshire OX29 8BD
UK
Phone: +44 7900 69 89 28
Fax: +44 1993 88 19 33
France
GenomeQuest SA
147, Avenue Paul Doumer
92500 Rueil Malmaison France
Phone: +33 (0)1 41 96 80 30
fax: +33 (0)1 41 96 80 31
Who We Are
Our Mission:
Accelerating Genomics Research through Comprehensive Gene Search
Genomics research holds the possibility for transforming personalized medicine, consumer industries and the environment. However, in order to make decisions organizations must integrate and provide a single view of silos of genomic data. Past approaches have relied on database technology and have not succeeded due to maintenance costs, poor user interfaces, lack of scalability, or inability to change. Our mission is to use search, not database technology to cost-effectively deliver relevant and comprehensive information to all research participants.
Our Vision:
A Unified View of Genomics Information
Our vision is to create a unified view of genomics information from every life science desktop, industry web site, or software application. We create the software and services to make genomic information ubiquitous, high-quality, and cost-effective for wide adoption by life science research enterprises. We are passionate to deliver ever greater ease-of-use and relevance to encourage expanded participation in the genomic revolution.
The Genesis of GenomeQuest
The company began in the multi-national Human Genome Project. While at INRIA, founder and high-performance computing luminary Dr. Jean-Jacques Codani developed and licensed technology used to map the human genome. He founded GenomeQuest, a bioinformatics company, and added a multi-disciplinary scientific team, including Dr. Andrzej Wozniak, a parallel systems architect and Dr. Henk Heus, a geneticist and computational biologist to perfect the new approach — combining sequences and attached keywords as primary database selectors to determine sequence relevance.
GenomeQuest quickly gained an outstanding reputation among bioinformatics and genomics visionaries at major pharmaceuticals like Pfizer, Akzo Nobel, DuPont, Servier Labs, and Aventis. In July 2002, Ron Ranauro, a computer scientist, software industry veteran and skilled entrepreneur joined the team to guide the business model.
In January 2004 the GenomeQuest web application was launched for a diverse audience in major pharmaceutical, biotechnology, and government institutes. GenomeQuest's utility and ease-of-use and ability to return relevant results quickly made it popular among lawyers, patent agents, and principal investigators. Leading companies, including EPO, Pfizer, Roche, Sanofi-Aventis, Novartis, Millennium, Chiron and many others chose GenomeQuest as their genomic research tool.
In 2005 Dr. Kamalakar Gulukota a trained physician with a passion for bioinformatics joined the company to lead the GenomeQuest product roadmap.
GenomeQuest is a privately held U.S. company with headquarters in Westborough, Massachusetts. Our French subsidiary is located in Rueil-Malmaison near Paris, France.